AACR logo

More articles from Review

Innate Immune Checkpoint Inhibitors: The Next Breakthrough in Medical Oncology?
Robert W. Lentz, Meryl D. Colton, Siddhartha S. Mitra, Wells A. Messersmith

Molecular Cancer Therapeutics Apr 2021, DOI: 10.1158/1535-7163.MCT-21-0041
Role of Polo-Like Kinase 4 (PLK4) in Epithelial Cancers and Recent Progress in its Small Molecule Targeting for Cancer Management
Debra R. Garvey, Gagan Chhabra, Mary A. Ndiaye, Nihal Ahmad

Molecular Cancer Therapeutics Apr 2021, 20 (4) 632-640; DOI: 10.1158/1535-7163.MCT-20-0741
Salting the Soil: Targeting the Microenvironment of Brain Metastases
Ethan S. Srinivasan, Aaron C. Tan, Carey K. Anders, Ann Marie Pendergast, Dorothy A. Sipkins, David M. Ashley, Peter E. Fecci, Mustafa Khasraw

Molecular Cancer Therapeutics Mar 2021, 20 (3) 455-466; DOI: 10.1158/1535-7163.MCT-20-0579
Targeting PIM Kinases to Overcome Therapeutic Resistance in Cancer
Rachel K. Toth, Noel A. Warfel

Molecular Cancer Therapeutics Jan 2021, 20 (1) 3-10; DOI: 10.1158/1535-7163.MCT-20-0535
Emerging CAR-T Cell Therapy for the Treatment of Triple-Negative Breast Cancer
Sundee Dees, Rajkumar Ganesan, Sanjaya Singh, Iqbal S. Grewal

Molecular Cancer Therapeutics Dec 2020, 19 (12) 2409-2421; DOI: 10.1158/1535-7163.MCT-20-0385
Therapeutic Targeting of Mitochondrial One-Carbon Metabolism in Cancer
Aamod S. Dekhne, Zhanjun Hou, Aleem Gangjee, Larry H. Matherly

Molecular Cancer Therapeutics Nov 2020, 19 (11) 2245-2255; DOI: 10.1158/1535-7163.MCT-20-0423
Ion Channels and Their Role in the Pathophysiology of Gliomas
Takeshi Takayasu, Kaoru Kurisu, Yoshua Esquenazi, Leomar Y. Ballester

Molecular Cancer Therapeutics Oct 2020, 19 (10) 1959-1969; DOI: 10.1158/1535-7163.MCT-19-0929
Chemotherapy and CDK4/6 Inhibitors: Unexpected Bedfellows
Patrick J. Roberts, Vishnu Kumarasamy, Agnieszka K. Witkiewicz, Erik S. Knudsen

Molecular Cancer Therapeutics Aug 2020, 19 (8) 1575-1588; DOI: 10.1158/1535-7163.MCT-18-1161
A Historic Perspective and Overview of H-Ras Structure, Oncogenicity, and Targeting
Lihua Shu, Dongsheng Wang, Nabil F. Saba, Zhuo G. Chen

Molecular Cancer Therapeutics Apr 2020, 19 (4) 999-1007; DOI: 10.1158/1535-7163.MCT-19-0660
The Ongoing Search for Biomarkers of CDK4/6 Inhibitor Responsiveness in Breast Cancer
Scott F. Schoninger, Stacy W. Blain

Molecular Cancer Therapeutics Jan 2020, 19 (1) 3-12; DOI: 10.1158/1535-7163.MCT-19-0253

Main menu

User menu

Search

More articles from Review

Pages

Articles

Info for

About MCT